Lara Wohlbold

1.8k total citations
20 papers, 1.4k citations indexed

About

Lara Wohlbold is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Lara Wohlbold has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in Lara Wohlbold's work include RNA Research and Splicing (7 papers), Cancer-related Molecular Pathways (5 papers) and Microtubule and mitosis dynamics (4 papers). Lara Wohlbold is often cited by papers focused on RNA Research and Splicing (7 papers), Cancer-related Molecular Pathways (5 papers) and Microtubule and mitosis dynamics (4 papers). Lara Wohlbold collaborates with scholars based in Germany and United States. Lara Wohlbold's co-authors include Elisa Izaurralde, Robert P. Fisher, Oliver Weichenrieder, Karl A. Merrick, Praveen Bawankar, Cátia Igreja, Ramona Weber, Stéphane Larochelle, Steffen Schmidt and Daniel Peter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Genes & Development.

In The Last Decade

Lara Wohlbold

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Wohlbold Germany 16 1.1k 332 192 159 92 20 1.4k
Lykourgos‐Panagiotis Zalmas United Kingdom 12 1.2k 1.0× 366 1.1× 131 0.7× 201 1.3× 62 0.7× 14 1.4k
Jennifer A. Perry United States 14 1.5k 1.3× 471 1.4× 300 1.6× 140 0.9× 83 0.9× 16 1.8k
Willem den Besten United States 16 938 0.8× 418 1.3× 206 1.1× 103 0.6× 93 1.0× 20 1.2k
Natalie Meyer Canada 5 1.2k 1.0× 351 1.1× 106 0.6× 337 2.1× 108 1.2× 7 1.5k
Seth J. Goldenberg United States 13 1.6k 1.4× 503 1.5× 208 1.1× 121 0.8× 109 1.2× 16 1.8k
Jarkko Ylanko Canada 10 1.4k 1.3× 582 1.8× 163 0.8× 184 1.2× 80 0.9× 13 1.6k
Katayoon H. Emami United States 9 1.2k 1.1× 331 1.0× 209 1.1× 119 0.7× 118 1.3× 10 1.4k
Dale S. Haines United States 25 1.2k 1.0× 541 1.6× 301 1.6× 138 0.9× 130 1.4× 45 1.4k
Leandros-Vassilios Vassiliou United Kingdom 3 1.4k 1.2× 734 2.2× 241 1.3× 297 1.9× 98 1.1× 4 1.6k
Vincenzo D’Angiolella United Kingdom 20 1.5k 1.3× 557 1.7× 476 2.5× 202 1.3× 96 1.0× 32 1.7k

Countries citing papers authored by Lara Wohlbold

Since Specialization
Citations

This map shows the geographic impact of Lara Wohlbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Wohlbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Wohlbold more than expected).

Fields of papers citing papers by Lara Wohlbold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Wohlbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Wohlbold. The network helps show where Lara Wohlbold may publish in the future.

Co-authorship network of co-authors of Lara Wohlbold

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Wohlbold. A scholar is included among the top collaborators of Lara Wohlbold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Wohlbold. Lara Wohlbold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Ramona, Tobias Raisch, Duygu Kuzuoğlu‐Öztürk, et al.. (2019). HELZ directly interacts with CCR4–NOT and causes decay of bound mRNAs. Life Science Alliance. 2(5). e201900405–e201900405. 15 indexed citations
2.
Chang, Chung-Te, Sowndarya Muthukumar, Ramona Weber, et al.. (2019). A low-complexity region in human XRN1 directly recruits deadenylation and decapping factors in 5′–3′ messenger RNA decay. Nucleic Acids Research. 47(17). 9282–9295. 32 indexed citations
3.
Peter, Daniel, Ramona Weber, Lara Wohlbold, et al.. (2017). GIGYF1/2 proteins use auxiliary sequences to selectively bind to 4EHP and repress target mRNA expression. Genes & Development. 31(11). 1147–1161. 59 indexed citations
4.
Grüner, Stefan, Daniel Peter, Ramona Weber, et al.. (2016). The Structures of eIF4E-eIF4G Complexes Reveal an Extended Interface to Regulate Translation Initiation. Molecular Cell. 64(3). 467–479. 88 indexed citations
5.
Peter, Daniel, Cátia Igreja, Ramona Weber, et al.. (2015). Molecular Architecture of 4E-BP Translational Inhibitors Bound to eIF4E. Molecular Cell. 57(6). 1074–1087. 120 indexed citations
6.
Boland, Andreas, Ying Chen, Tobias Raisch, et al.. (2013). Structure and assembly of the NOT module of the human CCR4–NOT complex. Nature Structural & Molecular Biology. 20(11). 1289–1297. 96 indexed citations
7.
Bawankar, Praveen, Belinda Loh, Lara Wohlbold, Steffen Schmidt, & Elisa Izaurralde. (2013). NOT10 and C2orf29/NOT11 form a conserved module of the CCR4-NOT complex that docks onto the NOT1 N-terminal domain. RNA Biology. 10(2). 228–244. 81 indexed citations
8.
Huntzinger, Eric, Duygu Kuzuoğlu‐Öztürk, Joerg E. Braun, et al.. (2012). The interactions of GW182 proteins with PABP and deadenylases are required for both translational repression and degradation of miRNA targets. Nucleic Acids Research. 41(2). 978–994. 88 indexed citations
9.
Wohlbold, Lara, Karl A. Merrick, Saurav De, et al.. (2012). Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells. PLoS Genetics. 8(8). e1002935–e1002935. 50 indexed citations
10.
Wohlbold, Lara, Praveen Bawankar, Eric Huntzinger, et al.. (2012). The structural basis for the interaction between the CAF1 nuclease and the NOT1 scaffold of the human CCR4–NOT deadenylase complex. Nucleic Acids Research. 40(21). 11058–11072. 104 indexed citations
11.
Horiuchi, Dai, Noelle E. Huskey, Leonard Kusdra, et al.. (2012). Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways. Proceedings of the National Academy of Sciences. 109(17). E1019–27. 64 indexed citations
12.
Merrick, Karl A., Lara Wohlbold, Chao Zhang, et al.. (2011). Switching Cdk2 On or Off with Small Molecules to Reveal Requirements in Human Cell Proliferation. Molecular Cell. 42(5). 624–636. 69 indexed citations
13.
Teplova, Marianna, et al.. (2011). Structure-function studies of nucleocytoplasmic transport of retroviral genomic RNA by mRNA export factor TAP. Nature Structural & Molecular Biology. 18(9). 990–998. 47 indexed citations
14.
Wohlbold, Lara & Robert P. Fisher. (2009). Behind the wheel and under the hood: Functions of cyclin-dependent kinases in response to DNA damage. DNA repair. 8(9). 1018–1024. 46 indexed citations
15.
Larochelle, Stéphane, Karl A. Merrick, Marie‐Emilie Terret, et al.. (2007). Requirements for Cdk7 in the Assembly of Cdk1/Cyclin B and Activation of Cdk2 Revealed by Chemical Genetics in Human Cells. Molecular Cell. 25(6). 839–850. 207 indexed citations
16.
17.
Kuip, Heiko van der, et al.. (2005). Mechanisms of Clinical Resistance to Small Molecule Tyrosine Kinase Inhibitors Targeting Oncogenic Tyrosine Kinases. PubMed. 5(2). 101–112. 11 indexed citations
18.
Wohlbold, Lara, et al.. (2005). Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death. Cell Death and Differentiation. 12(6). 627–636. 14 indexed citations
19.
Kuip, Heiko van der, et al.. (2003). Imatinib mesylate (STI571) prevents the mutator phenotype of Bcr-Abl in hematopoietic cell lines. Leukemia Research. 28(4). 405–408. 12 indexed citations
20.
Wohlbold, Lara, Heiko van der Kuip, Cornelius Miething, et al.. (2003). Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood. 102(6). 2236–2239. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lykourgos‐Panagiotis Zalmas Breakdown of academic impact, for papers by Jennifer A. Perry Breakdown of academic impact, for papers by Willem den Besten Breakdown of academic impact, for papers by Natalie Meyer Breakdown of academic impact, for papers by Seth J. Goldenberg Breakdown of academic impact, for papers by Jarkko Ylanko Breakdown of academic impact, for papers by Katayoon H. Emami Breakdown of academic impact, for papers by Dale S. Haines Breakdown of academic impact, for papers by Leandros-Vassilios Vassiliou Breakdown of academic impact, for papers by Vincenzo D’Angiolella
Rankless by CCL
2026